NATH BIO (India) Today

Equity ratings for NATH BIO GENES are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of November 2019 and ending today, the 27th of October 2021. Click here to learn more.
NATH BIO GENES cannot be verified against its exchange. Apparently, NATH BIO is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

NATH BIO Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. NATH BIO's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NATH BIO or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
NATH BIO GENES is not yet fully synchronised with the market data
NATH BIO GENES has some characteristics of a very speculative penny stock
NATH BIO GENES has accumulated about 213.79 M in cash with (219.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.25.
Legal NameNATH BIO GENES
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of NATH BIO's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
NATH BIO GENES (NATHBIOGEN) is traded on National Stock Exchange of India in India and employs 392 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 7.07 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NATH BIO's market, we take the total number of its shares issued and multiply it by NATH BIO's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. NATH BIO GENES operates under Basic Materials sector and is part of Agricultural Inputs industry. The entity has 19 M outstanding shares. NATH BIO GENES has accumulated about 213.79 M in cash with (219.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.25.
Check NATH BIO Probability Of Bankruptcy

NATHBIOGEN Stock Against Markets

Picking the right benchmark for NATH BIO stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NATH BIO stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NATH BIO is critical whether you are bullish or bearish towards NATH BIO GENES at a given time.
NATH BIO GENES cannot be verified against its exchange. Apparently, NATH BIO is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NATH BIO stock to make a market-neutral strategy. Peer analysis of NATH BIO could also be used in its relative valuation, which is a method of valuing NATH BIO by comparing valuation metrics with similar companies.

NATH BIO Corporate Executives

Elected by the shareholders, the NATH BIO's board of directors comprises two types of representatives: NATH BIO inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NATHBIOGEN. The board's role is to monitor NATH BIO's management team and ensure that shareholders' interests are well served. NATH BIO's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NATH BIO's outside directors are responsible for providing unbiased perspectives on the board's policies.
Devinder Khurana - CFO and VP of Fin.Profile
Check out Stocks Correlation. Note that the NATH BIO GENES information on this page should be used as a complementary analysis to other NATH BIO's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Tools for NATHBIOGEN Stock

When running NATH BIO GENES price analysis, check to measure NATH BIO's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NATH BIO is operating at the current time. Most of NATH BIO's value examination focuses on studying past and present price action to predict the probability of NATH BIO's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NATH BIO's price. Additionally, you may evaluate how the addition of NATH BIO to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go